EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0822
-0.0063 (-7.12%)
At close: Feb 20, 2026
EV Biologics Revenue
In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.
Revenue
9.47M
Revenue Growth
-70.48%
P/S Ratio
0.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
840.53K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 9.47M | -32.45K | -0.34% |
| Jun 30, 2017 | 9.51M | -33.14M | -77.71% |
| Jun 30, 2016 | 42.64M | -3.59M | -7.76% |
| Jun 30, 2015 | 46.23M | 1.77M | 3.99% |
| Jun 30, 2014 | 44.46M | 1.98M | 4.65% |
| Jun 30, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sorrento Therapeutics | 64.27M |
| Evofem Biosciences | 17.73M |
| SQZ Biotechnologies Company | 12.12M |
| Emmaus Life Sciences | 11.89M |
| Scorpius Holdings | 1.72M |
| Lipella Pharmaceuticals | 389.78K |
| Eastgate Biotech | 137.64K |
| THC Farmaceuticals | 18.52K |